Leonid Beigelman

3.4k total citations
100 papers, 2.3k citations indexed

About

Leonid Beigelman is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Leonid Beigelman has authored 100 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 27 papers in Epidemiology and 20 papers in Infectious Diseases. Recurrent topics in Leonid Beigelman's work include RNA and protein synthesis mechanisms (37 papers), DNA and Nucleic Acid Chemistry (32 papers) and Advanced biosensing and bioanalysis techniques (28 papers). Leonid Beigelman is often cited by papers focused on RNA and protein synthesis mechanisms (37 papers), DNA and Nucleic Acid Chemistry (32 papers) and Advanced biosensing and bioanalysis techniques (28 papers). Leonid Beigelman collaborates with scholars based in United States, Belgium and Finland. Leonid Beigelman's co-authors include Alexander Karpeisky, Nassim Usman, Jasenka Matulić‐Adamić, Daniel Herschlag, Alessio Peracchi, Shenglong Wang, Olke C. Uhlenbeck, Peter Haeberli, Carolyn Gonzalez and Vladimir Serebryany and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Leonid Beigelman

96 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonid Beigelman United States 27 1.8k 252 245 176 151 100 2.3k
T.C. Appleby United States 22 775 0.4× 361 1.4× 276 1.1× 272 1.5× 305 2.0× 29 1.5k
Darrell R. Davis United States 23 1.8k 1.0× 125 0.5× 99 0.4× 134 0.8× 53 0.4× 49 2.2k
José Gallego Spain 23 1.1k 0.6× 109 0.4× 179 0.7× 58 0.3× 96 0.6× 50 1.4k
Youwei Yan United States 22 1.1k 0.6× 625 2.5× 366 1.5× 280 1.6× 185 1.2× 34 2.4k
Joseph E. Wedekind United States 33 2.6k 1.4× 342 1.4× 110 0.4× 298 1.7× 52 0.3× 90 3.3k
John Goodchild United States 22 1.7k 0.9× 298 1.2× 288 1.2× 184 1.0× 24 0.2× 49 2.2k
Hung V. Le United States 20 755 0.4× 147 0.6× 85 0.3× 242 1.4× 310 2.1× 55 1.7k
Lori A. Kohlstaedt United States 17 1.5k 0.8× 1.7k 6.6× 188 0.8× 310 1.8× 77 0.5× 23 2.7k
René Coulombe Canada 19 768 0.4× 295 1.2× 252 1.0× 158 0.9× 115 0.8× 33 1.5k
Zuzana Hostomska United States 14 1.0k 0.6× 694 2.8× 77 0.3× 378 2.1× 397 2.6× 16 1.8k

Countries citing papers authored by Leonid Beigelman

Since Specialization
Citations

This map shows the geographic impact of Leonid Beigelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Beigelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Beigelman more than expected).

Fields of papers citing papers by Leonid Beigelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonid Beigelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Beigelman. The network helps show where Leonid Beigelman may publish in the future.

Co-authorship network of co-authors of Leonid Beigelman

This figure shows the co-authorship network connecting the top 25 collaborators of Leonid Beigelman. A scholar is included among the top collaborators of Leonid Beigelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonid Beigelman. Leonid Beigelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillemont, Jérôme, et al.. (2023). Synthesis of 7’‐Substituted 2’‐O‐4’‐C‐Ethylene Bridged Nucleic Acid (ENA)‐Thymidine Monomers. European Journal of Organic Chemistry. 27(1). 2 indexed citations
2.
Vanrusselt, Hannah, Dieudonné Buh Kum, Valério Taverniti, et al.. (2023). Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles. Journal of Virology. 97(10). e0072223–e0072223. 4 indexed citations
3.
Martínez‐Montero, Saúl, Vivek K. Rajwanshi, Rajendra K. Pandey, et al.. (2023). New Oligonucleotide 2′-O-Alkyl N3′→P5′ (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity. Nucleic Acid Therapeutics. 33(5). 319–328. 1 indexed citations
4.
Ushach, Irina, Ren Zhu, Elen Rosler, et al.. (2022). Targeting TLR9 agonists to secondary lymphoid organs induces potent immune responses against HBV infection. Molecular Therapy — Nucleic Acids. 27. 1103–1115. 4 indexed citations
5.
Liu, Cheng, Sandro Boland, Michael D. Scholle, et al.. (2021). Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development. Antiviral Research. 187. 105020–105020. 39 indexed citations
6.
Zhang, Qingling, Sandrine Vendeville, V. N. Serebryany, et al.. (2020). ALG-000184, a prodrug of capsid assembly modulator ALG-001075, demonstrates best-in-class preclinical characteristics for the treatment of chronic hepatitis B. Journal of Hepatology. 73. S880–S881. 4 indexed citations
7.
McClure, Matthew W., Elina Berliba, Tengiz Tsertsvadze, et al.. (2018). Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects. PLoS ONE. 13(10). e0204974–e0204974. 8 indexed citations
8.
Das, Debasis, Jian Hong, Shuhui Chen, et al.. (2011). Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry. 19(16). 4690–4703. 26 indexed citations
9.
Wang, Guangyi, Xiaomin Wu, Debasis Das, et al.. (2009). HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives. Bioorganic & Medicinal Chemistry Letters. 19(15). 4484–4487. 8 indexed citations
10.
Serebryany, Vladimir & Leonid Beigelman. (2003). Synthesis of 2′-O-Substituted Ribonucleosides. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1007–1009. 12 indexed citations
11.
Morrissey, Dylan, David A. Johnson, James A. McSwiggen, et al.. (2002). Characterization of nuclease‐resistant ribozymes directed against hepatitis B virus RNA*. Journal of Viral Hepatitis. 9(6). 411–418. 19 indexed citations
12.
Gebhardt, Frank, Frauke Leenders, Frank Czauderna, et al.. (2002). GeneBlocs Are Powerful Tools to Study and Delineate Signal Transduction Processes That Regulate Cell Growth and Transformation. Antisense and Nucleic Acid Drug Development. 12(3). 131–143. 27 indexed citations
13.
Karpeisky, Alexander, et al.. (2002). Scaleable and efficient synthesis of 2′-deoxy-2′-N-phthaloyl nucleoside phosphoramidites for oligonucleotide synthesis. Bioorganic & Medicinal Chemistry Letters. 12(22). 3345–3347. 14 indexed citations
14.
Zinnen, Shawn, Mike Wilson, Brent Dickinson, et al.. (2002). Selection, design, and characterization of a new potentially therapeutic ribozyme. RNA. 8(2). 214–228. 26 indexed citations
15.
Wang, Shenglong, et al.. (2001). Comparison of the hammerhead cleavage reactions stimulated by monovalent and divalent cations. RNA. 7(4). 537–545. 141 indexed citations
16.
Matulić‐Adamić, Jasenka, Andrew T. Daniher, Alexander Karpeisky, et al.. (2001). SYNTHESIS OF MODIFIED NUCLEOSIDE 5′-TRIPHOSPHATES FORIN VITROSELECTION OF CATALYTIC NUCLEIC ACIDS [1]. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 1113–1115. 2 indexed citations
17.
Minasov, G., Jasenka Matulić‐Adamić, Christopher J. Wilds, et al.. (2000). Crystal structure of an RNA duplex containing phenyl-ribonucleotides, hydrophobic isosteres of the natural pyrimidines. RNA. 6(11). 1516–1528. 7 indexed citations
18.
Beigelman, Leonid, Jasenka Matulić‐Adamić, Alexander Karpeisky, Peter Haeberli, & David Sweedler. (2000). [3] Base-modified phosphoramidite analogs of pyrimidine ribonucleosides for RNA structure-activity studies. Methods in enzymology on CD-ROM/Methods in enzymology. 317. 39–65. 4 indexed citations
19.
Jarvis, Thale C., Francine E. Wincott, L. J. Alby, et al.. (1996). Optimizing the Cell Efficacy of Synthetic Ribozymes. Journal of Biological Chemistry. 271(46). 29107–29112. 63 indexed citations
20.
Beigelman, Leonid, Alexander Karpeisky, & Nassim Usman. (1995). Synthesis of 6-Aza- & 6-Methyl-pyrimidine Ribonucleoside Phosphoramidites and Their Incorporation in Hammerhead Ribozymes. Nucleosides and Nucleotides. 14(3-5). 895–899. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T.C. Appleby Breakdown of academic impact, for papers by Darrell R. Davis Breakdown of academic impact, for papers by José Gallego Breakdown of academic impact, for papers by Youwei Yan Breakdown of academic impact, for papers by Joseph E. Wedekind Breakdown of academic impact, for papers by John Goodchild Breakdown of academic impact, for papers by Hung V. Le Breakdown of academic impact, for papers by Lori A. Kohlstaedt Breakdown of academic impact, for papers by René Coulombe Breakdown of academic impact, for papers by Zuzana Hostomska
Rankless by CCL
2026